Allergan fell$. 51 or. 3 percent, to $177.49. Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Boston Scientific Corp. fell$. 08 or. 7 percent, to $11.37.» Read More
May 28- Medtronic Inc has agreed to pay $9.9 million to the United States to settle claims it used kickbacks to induce doctors to implant its pacemakers and defibrillators in patients.
J&J said it was positioned for growth through new products recently launched and those in its pipeline and would place significant focus on fast-growing emerging markets, particularly China and Russia. J&J said it has the number one diabetes business in China, with a population that includes a quarter of the world's diabetics.
May 20- Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market. Edwards was first to market with its Sapien technology in 2011 in the United States, while Medtronic received U.S. regulatory approval for CoreValve in January.
May 20- Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. Medtronic said it would give Edwards a one-time payment of $750 million, plus ongoing royalty payments through April 2022, based on a percentage of CoreValve sales.
May 20- Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.
*Sees 2nd- qtr revenue $2.50 bln- $2.53 bln vs est. May 7- Technology outsourcing company Cognizant Technology Solutions Corp said growth in its North America healthcare business would remain slow this quarter due to lower spending by customers adjusting to U.S. healthcare reforms.
*Forecasts 2nd- quarter revenue $2.50 bln- $2.53 bln vs est. May 7- Technology outsourcing company Cognizant Technology Solutions Corp said growth in its North America healthcare business would remain slow this quarter due to lower spending by customers as they adjust to changes brought on by Obamacare.
WASHINGTON, April 30- The United States has resisted lobbying by U.S. drug and pharmaceutical companies to take tougher trade action against India for its intellectual property policies, deciding against risking ties with a likely new government in New Delhi.
April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..
April 24- Medical device maker Zimmer Holdings Inc said it would buy orthopedic products company Biomet Inc in a deal valued at about $13.35 billion to broaden its portfolio of products that treat bone and joint-related disorders.
April 24- Medical device maker Zimmer Holdings Inc said it would acquire orthopedic products company Biomet Inc in a deal valued at about $13.35 billion.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
As healthcare reform begins to take shape, venture capitalists see emerging opportunities in digital health start-ups.
P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.
The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."
Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.